Advertisement
Screener

Alkermes plc. (ALKS) Market Cap

Alkermes plc. Market Cap

Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.

  • Alkermes plc. market cap for the quarter ending 2026-07-23 was $8.89B, a 106.09% increase year-over-year.
  • Alkermes plc. market cap for the quarter ending 2026-06-30 was $8.78B, a 85.88% increase year-over-year.
  • Alkermes plc. market cap for the quarter ending 2026-04-30 was $5.62B, a 22.42% increase year-over-year.
  • Alkermes plc. market cap for the quarter ending 2026-03-31 was $5.89B, a 8.15% increase year-over-year.
  • Alkermes plc. market cap for fiscal 2026 was $8.89B.
  • Alkermes plc. market cap for fiscal 2025 was $4.63B, a 0.69% decline from fiscal 2024.
  • Alkermes plc. market cap for fiscal 2024 was $4.66B, a 0.69% increase from fiscal 2023.
  • Alkermes plc. market cap for fiscal 2023 was $4.63B, a 7.84% increase from fiscal 2022.
Available history
2011-03-31 to 2026-07-23
Data captured

Historical Market Cap

DateMarket Cap
2026-07-23$8.89B
2026-06-30$8.78B
2026-04-30$5.62B
2026-03-31$5.89B
2026-02-20$5.31B
2025-12-31$4.63B
2025-10-24$4.92B
2025-09-30$4.95B
2025-07-25$4.31B
2025-06-30$4.72B
2025-04-25$4.59B
2025-03-31$5.44B
2025-02-07$5.13B
2024-12-31$4.66B
2024-10-18$4.57B
2024-09-30$4.53B
2024-07-19$4.09B
2024-06-30$4B
2024-04-26$4.18B
2024-03-31$4.58B
2024-02-09$4.56B
2023-12-31$4.63B
2023-10-20$4.51B
2023-09-30$4.67B
2023-07-21$5.32B
2023-06-30$5.21B
2023-04-21$4.88B
2023-03-31$4.68B
2023-02-10$4.45B
2022-12-31$4.3B
2022-10-28$3.83B
2022-09-30$3.67B
2022-07-22$4.73B
2022-06-30$4.89B
2022-04-22$4.61B
2022-03-31$4.29B
2022-02-07$3.81B
2021-12-31$3.77B
2021-10-22$4.99B
2021-09-30$4.99B
2021-07-23$3.95B
2021-06-30$3.95B
2021-04-23$3.41B
2021-03-31$2.99B
2021-02-05$3.56B
2020-12-31$3.18B
2020-11-18$2.87B
2020-10-23$2.61B
2020-09-30$2.64B
2020-07-24$3.15B
2020-06-30$3.09B
2020-04-24$2.55B
2020-03-31$2.29B
2020-02-04$2.76B
2019-12-31$3.22B
2019-10-18$2.86B
2019-09-30$3.07B
2019-07-22$3.59B
2019-06-30$3.54B
2019-04-22$5.28B
2019-03-31$5.72B
2019-02-04$5.18B
2018-12-31$4.6B
2018-10-19$6.24B
2018-09-30$6.59B
2018-07-23$6.99B
2018-06-30$6.39B
2018-04-20$7.13B
2018-03-31$8.98B
2018-02-02$9.9B
2017-12-31$8.43B
2017-10-23$7.61B
2017-09-30$7.82B
2017-07-21$8.87B
2017-06-30$8.91B
2017-04-24$8.69B
2017-03-31$8.96B
2017-02-03$8.38B
2016-12-31$8.47B
2016-10-24$8.62B
2016-09-30$7.14B
2016-07-22$7.55B
2016-06-30$6.55B
2016-04-22$6.45B
2016-03-31$5.17B
2016-02-12$4.89B
2015-12-31$11.96B
2015-10-26$9.37B
2015-09-30$8.79B
2015-07-27$10B
2015-06-30$9.61B
2015-04-24$9.25B
2015-03-31$9.05B
2015-02-12$10.85B
2014-12-31$8.64B
2014-10-24$6.71B
2014-09-30$6.26B
2014-07-25$6.55B
2014-06-30$7.33B
2014-04-24$6.69B

Annual Market Cap

DateMarket Cap
2026-07-23$8.89B
2025-12-31$4.63B
2024-12-31$4.66B
2023-12-31$4.63B
2022-12-31$4.3B
2021-12-31$3.77B
2020-12-31$3.18B
2019-12-31$3.22B
2018-12-31$4.6B
2017-12-31$8.43B
2016-12-31$8.47B
2015-12-31$11.96B
2014-12-31$8.64B
2013-12-31$5.6B
2012-12-31$2.45B
2011-11-01$2.19B

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76